Fibernet Builds Competitive 10G Fiber Network with Adtran
17.5.2022 12:30:00 EEST | Business Wire | Press release
Adtran, Inc., (NASDAQ: ADTN), the leading provider of next-generation multi-gigabit fiber access and fiber extension solutions, today announced Fibernet is leveraging the Adtran 10G Fiber Access Platform to build an XGS-PON fiber network that will connect 50,000 customers in its first phase. Fibernet is leveraging its innovative fiber trenching technology to quickly build a fiber network and is using Adtran’s reliable 10G solutions to deploy competitive, scalable broadband services to households and businesses in Finland.
Fibernet is a new alternative network provider (altnet) in Finland, where much of the country can access 4G mobile broadband coverage. However, increased demand for high-bandwidth, reliable internet means that fiber connections are a necessity. While some established service providers began slowly building expensive fiber networks, Fibernet invested in an innovative fiber trenching approach that allows the altnet to build its network much faster. Fibernet selected the Adtran 10G Fiber Access Platform as its foundation to launch high-quality, competitive broadband services for internet, IPTV, telehealth and more.
“While Fibernet is new to this market, our leaders have deep experience in implementing superior broadband networks. We selected Adtran because of its experience in both the fiber access and altnet markets, and together we make a great team. We are extremely pleased with the support that Adtran has provided in our startup phase,” said Janne Ahola, CEO at Fibernet. “We understand that fiber is the only way to supply fast and reliable network connections that can scale with subscriber demands. Adtran provides a solution that can help us meet those needs today and in the future.”
The Adtran 10G Fiber Access Platform leverages the symmetrical upload and download speeds of XGS-PON technology, which future-proofs the network against growing demand for high-bandwidth cloud and streaming services. Adtran’s supply availability is also a differentiator for Fibernet. In Finland, the ground is frozen for five months each year. The long winters require well-planned building seasons and hardware deliveries must be on schedule during the warmer months. Adtran offers a comprehensive end-to-end access portfolio that allows Fibernet to order most of the hardware from a single vendor to better ensure on-time deliveries.
“Fibernet has a key advantage with its micro-trenching technology that lets it build its fiber network much faster. With Adtran in its network, Fibernet can match that innovation with a 10G fiber access platform that will provide reliable, high-quality services today and grow with them as subscriber demands evolve,” said Stuart Broome, Vice President of Sales, EMEA at Adtran. “The ease of scalability will enable Fibernet to increase capacity and scale services beyond its traditional residential subscriber base to support the connectivity needs of local small- and mid-sized businesses as well.”
For more information about the Adtran 10G Fiber Access Platform, visit www.adtran.com/fiber-access.
About Adtran
Adtran, Inc. is a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are currently in use by service providers, private enterprises, government organizations and millions of individual users worldwide. Find more at Adtran, LinkedIn and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517005203/en/
Contact information
Ashley Schulte
ashley.schulte@adtran.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
